Researchers have identified a specific change in the SARS-CoV-2 coronavirus spike protein that may increase its transmission, making it more infectious in cell culture.
Researchers at Cedars-Sinai Medical Center have discovered that SARS-CoV-2 can infect human myocardiocytes in vitro. COVID-19 infection can cause heart problems. This study demonstrates that this could be due to direct infection of myocardiocytes by the virus.
Harvard’s Wyss Institute is leveraging its unique technology innovation capabilities to develop diagnostic, therapeutic, and vaccine interventions for COVID-19 at lightning speed.
Researchers have accurately profiled the immune response to COVID-19 in critically ill patients, allowing them to identify six inflammatory molecules as potential targets for COVID-19 treatment.
In this interview we speak to José Javier García from Pivotal about his company´s involvement in a large-scale clinical trial testing the safety and efficacy of hyperimmune convalescent plasma treatment in COVID-19 patients.
Researchers at the University of Toronto have revealed the binding action of the bacterial toxin responsible for toxic shock syndrome. Although similar to the toxin that causes diarrhea, the two proteins behave differently due to a short amino acid sequence, which the researchers were able to manipulate.
Researchers at the Emory Vaccine Center have demonstrated that a novel adjuvant, 3M-052, can aid long-lasting immunity against HIV in rhesus monkeys. This could have implications for developing successful vaccines against HIV, influenza and COVID-19.
Take a peek behind the scenes of a recent article published by Future Virology, titled ‘Pros and cons of the application…
Rebiotix (MN, USA) recently announced positive preliminary results from an ongoing clinical trial investigating the use of an investigational microbiota-based formulation, RBX2660, for the reduction of C. diff infection.